Ascentage Pharma Group International (AAPG) Receivables - Other (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Receivables - Other for 3 consecutive years, with $205144.2 as the latest value for Q4 2025.
- For Q4 2025, Receivables - Other fell 75.99% year-over-year to $205144.2; the TTM value through Dec 2025 reached $205144.2, down 75.99%, while the annual FY2025 figure was $208000.0, 75.27% down from the prior year.
- Receivables - Other hit $205144.2 in Q4 2025 for Ascentage Pharma Group International, down from $854366.9 in the prior quarter.
- Across five years, Receivables - Other topped out at $921795.6 in Q4 2023 and bottomed at $205144.2 in Q4 2025.
- Average Receivables - Other over 3 years is $660435.6, with a median of $854366.9 recorded in 2024.
- Year-over-year, Receivables - Other dropped 7.31% in 2024 and then crashed 75.99% in 2025.
- Ascentage Pharma Group International's Receivables - Other stood at $921795.6 in 2023, then fell by 7.31% to $854366.9 in 2024, then plummeted by 75.99% to $205144.2 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods came in at $205144.2, $854366.9, and $921795.6 for Q4 2025, Q4 2024, and Q4 2023 respectively.